Cargando…

The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity

BACKGROUND: Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60–70%. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohberger, Birgit, Stuendl, Nicole, Wolf, Elisabeth, Liegl-Atzwanger, Bernadette, Leithner, Andreas, Rinner, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219478/
https://www.ncbi.nlm.nih.gov/pubmed/24289252
http://dx.doi.org/10.1186/1471-2407-13-563
_version_ 1782342591753224192
author Lohberger, Birgit
Stuendl, Nicole
Wolf, Elisabeth
Liegl-Atzwanger, Bernadette
Leithner, Andreas
Rinner, Beate
author_facet Lohberger, Birgit
Stuendl, Nicole
Wolf, Elisabeth
Liegl-Atzwanger, Bernadette
Leithner, Andreas
Rinner, Beate
author_sort Lohberger, Birgit
collection PubMed
description BACKGROUND: Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60–70%. METHODS: After the establishment of the novel myxofibrosarcoma cell lines MUG-Myx1, cells were characterized using short tandem repeat (STR), copy number variation (CNV), and genotype/loss-of-heterozygosity (LOH) analyses. The growth behaviour of the cells was analyzed with the xCELLigence system and an MTS assay. The tumourigenicity of MUG-Myx1 was proved in NOD/SCID mice. Additionally, a stem-like cell population with high enzymatic activity of aldehyde dehydrogenase 1 (ALDH1(high)) was isolated for the first time from myxofibrosarcoma cells using the Aldefluor® assay followed by FACS analysis. RESULTS: The frozen primary parental tumour tissue and the MUG-Myx1 cell line showed the same STR profile at the markers D3S1358, TH01, D21S11, D18S51, Penta E, D5S818, D13S317, D7S820, D16S539, CSF1PO, Penta D, Amelogenin, D8S1179, TPOX, and FGY. Typically, myxofibrosarcoma gain and/or amplification was mapped to 7p21.3-q31.1, q31.1-q31.33, q33-q36.2, p21.3, p21.2, p14.1-q11.23, q31.33-q33, p21.2-p14.1, q11.23-q21.3, q36.2-q36.3, which, respectively are known to harbour tumour-associated genes, including TIF, BRAF, MLL3, SMO, and MET. Typically an LOH for myxofibrosarcoma on chr5 q21 was found. In addition, MUG-Myx1 ALDH1(high) cells showed an upregulation of the ABC transporter ABCB1 and ABCG2; higher c-Myc, E-cadherin and SOX-2 expression; and a higher potential for tumourigenicity and proliferation levels. CONCLUSION: The new myxofibrosarcoma cell line MUG-Myx1 was established to enrich the bank of publicly available cell lines, with respect to providing comprehensive genetic and epigenetic characterization. Furthermore, because of their tumourigenicity, the cell line is also suitable for in vivo experiments.
format Online
Article
Text
id pubmed-4219478
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42194782014-11-05 The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity Lohberger, Birgit Stuendl, Nicole Wolf, Elisabeth Liegl-Atzwanger, Bernadette Leithner, Andreas Rinner, Beate BMC Cancer Research Article BACKGROUND: Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixth to eighth decades of life and the overall 5-year survival rate is 60–70%. METHODS: After the establishment of the novel myxofibrosarcoma cell lines MUG-Myx1, cells were characterized using short tandem repeat (STR), copy number variation (CNV), and genotype/loss-of-heterozygosity (LOH) analyses. The growth behaviour of the cells was analyzed with the xCELLigence system and an MTS assay. The tumourigenicity of MUG-Myx1 was proved in NOD/SCID mice. Additionally, a stem-like cell population with high enzymatic activity of aldehyde dehydrogenase 1 (ALDH1(high)) was isolated for the first time from myxofibrosarcoma cells using the Aldefluor® assay followed by FACS analysis. RESULTS: The frozen primary parental tumour tissue and the MUG-Myx1 cell line showed the same STR profile at the markers D3S1358, TH01, D21S11, D18S51, Penta E, D5S818, D13S317, D7S820, D16S539, CSF1PO, Penta D, Amelogenin, D8S1179, TPOX, and FGY. Typically, myxofibrosarcoma gain and/or amplification was mapped to 7p21.3-q31.1, q31.1-q31.33, q33-q36.2, p21.3, p21.2, p14.1-q11.23, q31.33-q33, p21.2-p14.1, q11.23-q21.3, q36.2-q36.3, which, respectively are known to harbour tumour-associated genes, including TIF, BRAF, MLL3, SMO, and MET. Typically an LOH for myxofibrosarcoma on chr5 q21 was found. In addition, MUG-Myx1 ALDH1(high) cells showed an upregulation of the ABC transporter ABCB1 and ABCG2; higher c-Myc, E-cadherin and SOX-2 expression; and a higher potential for tumourigenicity and proliferation levels. CONCLUSION: The new myxofibrosarcoma cell line MUG-Myx1 was established to enrich the bank of publicly available cell lines, with respect to providing comprehensive genetic and epigenetic characterization. Furthermore, because of their tumourigenicity, the cell line is also suitable for in vivo experiments. BioMed Central 2013-12-01 /pmc/articles/PMC4219478/ /pubmed/24289252 http://dx.doi.org/10.1186/1471-2407-13-563 Text en Copyright © 2013 Lohberger et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lohberger, Birgit
Stuendl, Nicole
Wolf, Elisabeth
Liegl-Atzwanger, Bernadette
Leithner, Andreas
Rinner, Beate
The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
title The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
title_full The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
title_fullStr The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
title_full_unstemmed The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
title_short The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
title_sort novel myxofibrosarcoma cell line mug-myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219478/
https://www.ncbi.nlm.nih.gov/pubmed/24289252
http://dx.doi.org/10.1186/1471-2407-13-563
work_keys_str_mv AT lohbergerbirgit thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT stuendlnicole thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT wolfelisabeth thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT lieglatzwangerbernadette thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT leithnerandreas thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT rinnerbeate thenovelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT lohbergerbirgit novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT stuendlnicole novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT wolfelisabeth novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT lieglatzwangerbernadette novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT leithnerandreas novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity
AT rinnerbeate novelmyxofibrosarcomacelllinemugmyx1expressesatumourigenicstemlikecellpopulationwithhighaldehydedehydrogenase1activity